Ameriprise’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-896
| Closed | -$16K | – | 4067 |
|
|
2022
Q3 | $16K | Sell |
896
-475
| -35% | -$8.48K | ﹤0.01% | 3920 |
|
|
2022
Q2 | $30K | Sell |
1,371
-433
| -24% | -$9.48K | ﹤0.01% | 3842 |
|
|
2022
Q1 | $50K | Sell |
1,804
-241
| -12% | -$6.68K | ﹤0.01% | 3875 |
|
|
2021
Q4 | $93K | Sell |
2,045
-1,058
| -34% | -$48.1K | ﹤0.01% | 3872 |
|
|
2021
Q3 | $259K | Sell |
3,103
-283
| -8% | -$23.6K | ﹤0.01% | 3630 |
|
|
2021
Q2 | $322K | Sell |
3,386
-18,375
| -84% | -$1.75M | ﹤0.01% | 3610 |
|
|
2021
Q1 | $3.62M | Buy |
+21,761
| New | +$3.62M | ﹤0.01% | 2584 |
|
|
2014
Q2 | – | Sell |
-15
| Closed | -$32K | – | 5653 |
|
|
2014
Q1 | $32K | Sell |
15
-88
| -85% | -$188K | ﹤0.01% | 3976 |
|
|
2013
Q4 | $239K | Sell |
103
-6
| -6% | -$13.9K | ﹤0.01% | 3082 |
|
|
2013
Q3 | $307K | Buy |
109
+108
| +10,800% | +$304K | ﹤0.01% | 3022 |
|
|
2013
Q2 | $12K | Buy |
+1
| New | +$12K | ﹤0.01% | 4652 |
|